GlassScriptPhysician profile
Peter M Strassberg
NPI 1922167964
$1,708.97
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $564 · 2020: $317 · 2021: $270 · 2022: $272 · 2023: $248 · 2024: $38.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $286.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $285.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $379.88 | 2019-2023 | Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $348.72 | 2019-2024 | Farxiga, Fasenra, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $339.51 | 2019-2023 | Jardiance, Spiriva Respimat |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $190.37 | 2019-2023 | Xifaxan |
| Pfizer INC. | $103.92 | 2019-2020 | |
| Novo Nordisk INC | $99.08 | 2021-2022 | |
| Lilly USA, LLC | $56.15 | 2021-2024 | Zepbound, Jardiance |
| Genentech USA, INC. | $50.84 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $29.55 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $24.08 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $19.40 | 2020 | |
| Janssen Pharmaceuticals, INC | $17.95 | 2020 | |
| Exact Sciences Corporation | $14.42 | 2023 | Cologuard Collection Kit |
| Amarin Pharma, INC. | $12.65 | 2021 | |
| Avanir Pharmaceuticals, INC. | $11.57 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $10.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Strassberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.